{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:49:20Z","timestamp":1791578960793,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.103982","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:41:16Z","timestamp":1790134876000},"page":"103982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P3","title":["Syntaxin 1\u202fA knockdown suppresses hepatocellular carcinoma cell viability and invasion but induces apoptosis primarily through the AKT pathway"],"prefix":"10.1016","volume":"104","author":[{"given":"Junduo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib1","doi-asserted-by":"crossref","DOI":"10.1080\/20450923.2025.2493457","article-title":"Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy","volume":"12","author":"Akabane","year":"2025","journal-title":"Hepatic Oncol."},{"issue":"10","key":"10.1016\/j.tice.2026.103982_bib2","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.3390\/cancers12102755","article-title":"Targeting Ca(2+) signaling in the initiation, promotion and progression of hepatocellular carcinoma","volume":"12","author":"Ali","year":"2020","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.tice.2026.103982_bib3","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/10799893.2020.1837870","article-title":"CXCL14 inhibits the growth and promotes apoptosis of hepatocellular carcinoma cells via suppressing Akt\/mTOR pathway","volume":"41","author":"Bi","year":"2021","journal-title":"J. Recept. Signal. Transduct. Res."},{"issue":"3","key":"10.1016\/j.tice.2026.103982_bib4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13402-013-0132-x","article-title":"Composite fatty acid ether amides suppress growth of liver cancer cells in vitro and in an in vivo allograft mouse model","volume":"36","author":"Cao","year":"2013","journal-title":"Cell. Oncol."},{"issue":"Pt 1","key":"10.1016\/j.tice.2026.103982_bib5","article-title":"Radiation-responsive Salmonella mediate therapeutics precise delivery for synergistic tumor radio-immunotherapy","volume":"388","author":"Chen","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"7","key":"10.1016\/j.tice.2026.103982_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-25-2944","article-title":"Targeting tumor-associated macrophages and cancer-associated fibroblasts to overcome therapeutic resistance in hepatocellular carcinoma","volume":"32","author":"Cho","year":"2026","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.tice.2026.103982_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/srep17669","article-title":"SUMOylation of Syntaxin1A regulates presynaptic endocytosis","volume":"5","author":"Craig","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103982_bib8","article-title":"Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: molecular mechanisms and therapeutic implications","volume":"45","author":"Das","year":"2026","journal-title":"Biochem. Biophys. Rep."},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.cld.2025.06.009","article-title":"Novel therapeutics for hepatocellular carcinoma","volume":"29","author":"Elsaid","year":"2025","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.tice.2026.103982_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3390\/curroncol33030172","article-title":"The state of the art in combination locoregional and systemic treatment strategies for hepatocellular carcinoma: recent advancements and future horizons","volume":"33","author":"Fazlollahi","year":"2026","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.tice.2026.103982_bib11","first-page":"854","article-title":"MAPK\/ERK signaling in tumorigenesis: mechanisms of growth, invasion, and angiogenesis","volume":"24","author":"Fei","year":"2025","journal-title":"EXCLI J."},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s13167-025-00428-1","article-title":"Glioma angiogenesis phosphoproteome landscape and biomarker sets identified with phenome-centered multiomics toward 3P medical approaches","volume":"16","author":"Gong","year":"2025","journal-title":"EPMA J."},{"issue":"14","key":"10.1016\/j.tice.2026.103982_bib13","doi-asserted-by":"crossref","first-page":"13137","DOI":"10.1007\/s00432-023-05042-0","article-title":"A novel tumor microenvironment-related gene signature with immune features for prognosis of lung squamous cell carcinoma","volume":"149","author":"Han","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12672-026-04399-1","article-title":"Therapeutic potential of diosgenin in hepatocellular carcinoma through molecular mechanisms and nanodelivery strategies","volume":"17","author":"Jyotishi","year":"2026","journal-title":"Discov. Oncol."},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/ijms21041213","article-title":"Syntaxin 1: a novel robust immunophenotypic marker of neuroendocrine tumors","volume":"21","author":"K\u0151v\u00e1ri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103982_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.683629","article-title":"LLGL2 increases Ca(2+) influx and exerts oncogenic activities via PI3K\/AKT signaling pathway in hepatocellular carcinoma","volume":"11","author":"Leng","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-026-02578-w","article-title":"Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities","volume":"25","author":"Li","year":"2026","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.scib.2025.12.022","article-title":"Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries\/territories in 2022","volume":"71","author":"Li","year":"2026","journal-title":"Sci. Bull."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib19","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1186\/s12885-025-14948-6","article-title":"Clinicopathological significance of AKT and phosphorylated AKT expression in hepatocellular carcinoma: a meta-analysis","volume":"25","author":"Ma","year":"2025","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.tice.2026.103982_bib20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuropharm.2004.10.017","article-title":"Munc18-dependent regulation of synaptic vesicle exocytosis by syntaxin-1A in hippocampal neurons","volume":"48","author":"Mitchell","year":"2005","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.tice.2026.103982_bib21","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/cancers13123026","article-title":"MAPK\/ERK signaling pathway in hepatocellular carcinoma","volume":"13","author":"Moon","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.tice.2026.103982_bib22","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i11.109923","article-title":"Targeting the Osteopontin-regulated PI3K\/AKT signaling pathway: a molecular approach to overcome drug resistance and metastasis in gastrointestinal tumors","volume":"17","author":"Nian","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.tice.2026.103982_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13577-025-01195-x","article-title":"STX1A regulates ferroptosis and chemoresistance in gastric cancer through mitochondrial function modulation","volume":"38","author":"Niu","year":"2025","journal-title":"Human. Cell."},{"issue":"13_ement","key":"10.1016\/j.tice.2026.103982_bib24","article-title":"Abstract 5079: role of syntaxin-1A, a synaptic-related protein, in HER2-enriched and luminal B breast cancer progression","volume":"78","author":"Noguera-Castells","year":"2018","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.tice.2026.103982_bib25","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1523\/JNEUROSCI.22-09-03342.2002","article-title":"Regulation of exocytosis through Ca2+\/ATP-dependent binding of autophosphorylated Ca2+\/calmodulin-activated protein kinase II to syntaxin 1A","volume":"22","author":"Ohyama","year":"2002","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1590\/1678-4685-gmb-2017-0339","article-title":"Increased expression levels of Syntaxin 1A and synaptobrevin 2\/vesicle-associated membrane protein-2 are associated with the progression of bladder cancer","volume":"42","author":"Raja","year":"2019","journal-title":"Genet. Mol. Biol."},{"issue":"52","key":"10.1016\/j.tice.2026.103982_bib27","doi-asserted-by":"crossref","first-page":"43825","DOI":"10.1074\/jbc.M112.409649","article-title":"Munc18-1 controls SNARE protein complex assembly during human sperm acrosomal exocytosis","volume":"287","author":"Rodr\u00edguez","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.tice.2026.103982_bib28","first-page":"1263","article-title":"Mitochondrial fission promotes cell migration by Ca(2+) \/CaMKII\/ERK\/FAK pathway in hepatocellular carcinoma","volume":"38","author":"Sun","year":"2018","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"issue":"D1","key":"10.1016\/j.tice.2026.103982_bib29","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.tice.2026.103982_bib30","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12957-025-04023-6","article-title":"P2RX4 promotes hepatocellular carcinoma progression via calcium-mediated PI3K\/AKT activation and immune remodeling","volume":"23","author":"Wang","year":"2025","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.tice.2026.103982_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s12013-014-0011-8","article-title":"CAMK1 phosphoinositide signal-mediated protein sorting and transport network in human hepatocellular carcinoma (HCC) by biocomputation","volume":"70","author":"Wang","year":"2014","journal-title":"Cell. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.tice.2026.103982_bib33","first-page":"110","article-title":"CRISPR\/Cas9 screenings reveal the role of STX1A and CDK1 in Cathepsin G entering and killing colorectal cancer cells","volume":"31","author":"Wang","year":"2025","journal-title":"Interdiscip. Inf. Sci."},{"issue":"Pt 3","key":"10.1016\/j.tice.2026.103982_bib34","article-title":"Targeting AKT to treat liver disease: opportunities and challenges","volume":"242","author":"Wang","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib35","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1074\/jbc.M111.290882","article-title":"A Ca(v)3.2\/syntaxin-1A signaling complex controls T-type channel activity and low-threshold exocytosis","volume":"287","author":"Weiss","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tice.2026.103982_bib36","article-title":"RNA splicing dysregulation in hepatocellular carcinoma: molecular mechanisms, therapeutic targets, and intervention strategies-a comprehensive review","volume":"195","author":"Xiong","year":"2026","journal-title":"Biomed. Pharmacother. Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.tice.2026.103982_bib37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/apm.13113","article-title":"The panel of syntaxin 1 and insulinoma-associated protein 1 outperforms classic neuroendocrine markers in pulmonary neuroendocrine neoplasms","volume":"129","author":"Zombori","year":"2021","journal-title":"APMIS Acta Pathol. Microbiol. Et. Immunol. Scand."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626006786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626006786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:58:18Z","timestamp":1791575898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626006786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":37,"alternative-id":["S0040816626006786"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103982","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syntaxin 1\u202fA knockdown suppresses hepatocellular carcinoma cell viability and invasion but induces apoptosis primarily through the AKT pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103982"}}